Bin Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bin Yu has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Nan Jiang
Division of Orthopaedics and Traumatology, Department of Orthopaedics Nanfang Hospital, Southern Medical University Guangzhou China
37 shared publications - Xianrong Zhang
Division of Orthopaedics and Traumatology, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, Guangzhou, China
14 shared publications Qing-Rong Lin
Guangdong Institute of Orthopaedics & Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
10 shared publicationsLei Wang
Division of Orthopaedics and Traumatology, Department of Orthopedics, Nanfang Hospital, Southern Medical University, Guangzhou, China
9 shared publicationsYan-Jun Hu
Division of Orthopaedics & Traumatology, Department of Orthopaedics, Southern Medical University Nanfang Hospital, Guangzhou, China
9 shared publicationsNan Jiang
Guangdong Institute of Orthopaedics & Traumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China
8 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (8) , 588
Combined multi-omics profiling and machine learning analysis reveals that Bregs and RPS2 promote bone metastasis in nasopharyngeal carcinoma
Background: The bone is the primary site of distant metastasis in patients with nasopharyngeal carcinoma (NPC), and bone metastasis (BM) significantly increases mortality. Deciphering the complex crosstalk between cancer cells and their tumor microenvironment (TME) is crucial for identifying therapeutic targets aimed at eliminating metastasis-initiating cells and preventing the establishment of overt metastases. Regulatory B cells (Bregs), a specialized B-cell subset endowed with potent immunosuppressive functions, play a pivotal regulatory role within the TME. However, their specific contributions, phenotypic characteristics, and underlying molecular mechanisms within the BM niche of NPC remain incompletely characterized and await full elucidation. This study aims to investigate the infiltration dynamics, functional impact, and molecular underpinnings of Bregs in the context of NPC BM. Methods: The single-cell sequencing data and RNA sequencing (RNA-seq) microarray matrices from public databases were utilized for the analysis in this study. Subsequently, three machine learning methods, least absolute shrinkage and selection operator (LASSO) regression analysis, random forest algorithm, and Boruta algorithm were combined to identify prognostic genes. The high infiltration of Bregs and high expression of RPS2 in the primary lesions of BM patients were confirmed, and relevant prognostic signatures were constructed. Flow cytometry, cell counting kit-8 (CCK-8) assay, migration assay, Transwell assay, and co-culture system were used to evaluate the effects of Bregs on cell proliferation and metastasis. An animal model of intracardiac injection-induced tumor transplantation was established, and bioluminescence imaging (BLI), digital radiography (DR), and micro computed tomography (Micro-CT) were utilized to assess the impact of Bregs on BM of tumor cells. Finally, clinical cohort analysis was conducted to determine the correlation between Bregs and BM in NPC. Results: Bregs exhibit high infiltration in the primary lesions of NPC with BM, and the high expression of RPS2 in Bregs is highly correlated with prognosis. Mechanistically, RPS2 upregulates the secretion of interleukin-10 (IL-10) by Bregs. IL-10 then activates the PI3K/AKT pathway, which in turn upregulates the expression of the CXCR6 on the surface of tumor cells. These tumor cells, under the attraction of CXCL16 secreted by macrophages in bone, show an increased tendency to undergo BM. In the primary lesions of NPC patients, Bregs expressing RPS2 within tertiary lymphoid structures are highly associated with BM. Conclusions: Bregs and RPS2 can be utilized for the prognostic evaluation of BM in NPC. Pharmacological inhibition targeting Bregs or IL-10 may be a feasible approach to delay and treat BM in NPC.
- 1 August 2026
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (8) , 588
Open AccessCombined multi-omics profiling and machine learning analysis reveals that Bregs and RPS2 promote bone metastasis in nasopharyngeal carcinoma
Background: The bone is the primary site of distant metastasis in patients with nasopharyngeal carcinoma (NPC), and bone metastasis (BM) significantly increases mortality. Deciphering the complex crosstalk between cancer cells and their tumor microenvironment (TME) is crucial for identifying therapeutic targets aimed at eliminating metastasis-initiating cells and preventing the establishment of overt metastases. Regulatory B cells (Bregs), a specialized B-cell subset endowed with potent immunosuppressive functions, play a pivotal regulatory role within the TME. However, their specific contributions, phenotypic characteristics, and underlying molecular mechanisms within the BM niche of NPC remain incompletely characterized and await full elucidation. This study aims to investigate the infiltration dynamics, functional impact, and molecular underpinnings of Bregs in the context of NPC BM. Methods: The single-cell sequencing data and RNA sequencing (RNA-seq) microarray matrices from public databases were utilized for the analysis in this study. Subsequently, three machine learning methods, least absolute shrinkage and selection operator (LASSO) regression analysis, random forest algorithm, and Boruta algorithm were combined to identify prognostic genes. The high infiltration of Bregs and high expression of RPS2 in the primary lesions of BM patients were confirmed, and relevant prognostic signatures were constructed. Flow cytometry, cell counting kit-8 (CCK-8) assay, migration assay, Transwell assay, and co-culture system were used to evaluate the effects of Bregs on cell proliferation and metastasis. An animal model of intracardiac injection-induced tumor transplantation was established, and bioluminescence imaging (BLI), digital radiography (DR), and micro computed tomography (Micro-CT) were utilized to assess the impact of Bregs on BM of tumor cells. Finally, clinical cohort analysis was conducted to determine the correlation between Bregs and BM in NPC. Results: Bregs exhibit high infiltration in the primary lesions of NPC with BM, and the high expression of RPS2 in Bregs is highly correlated with prognosis. Mechanistically, RPS2 upregulates the secretion of interleukin-10 (IL-10) by Bregs. IL-10 then activates the PI3K/AKT pathway, which in turn upregulates the expression of the CXCR6 on the surface of tumor cells. These tumor cells, under the attraction of CXCL16 secreted by macrophages in bone, show an increased tendency to undergo BM. In the primary lesions of NPC patients, Bregs expressing RPS2 within tertiary lymphoid structures are highly associated with BM. Conclusions: Bregs and RPS2 can be utilized for the prognostic evaluation of BM in NPC. Pharmacological inhibition targeting Bregs or IL-10 may be a feasible approach to delay and treat BM in NPC.
- 28 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 184, 116924
Nox4 mediates chondrocyte senescence and cartilage degradation in post-traumatic osteoarthritis via the ROS/p38MAPK signaling pathway
- 28 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 184, 116924
Nox4 mediates chondrocyte senescence and cartilage degradation in post-traumatic osteoarthritis via the ROS/p38MAPK signaling pathway
- Open Access
- 9 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103176
A honeysuckle-decorated nanoimmunomodulator hijacks Macrophage-BMSC crosstalk to promote arthritic regeneration
- 9 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103176
Open AccessA honeysuckle-decorated nanoimmunomodulator hijacks Macrophage-BMSC crosstalk to promote arthritic regeneration
- Open Access
- 8 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Knowledge, attitude, and practice of osteoporosis and hip fracture in older Chinese adults
This study assessed the knowledge, attitude, and practices (KAP) regarding osteoporosis and hip fracture among older adults in Ningxia, China, to inform better prevention and management strategies through patient education and lifestyle changes. This cross-sectional study surveyed older adults at Ningxia Hui Autonomous Region People’s Hospital (Sep 2022–Nov 2023) using a convenience sampling method, collecting demographic data and assessing KAP scores. Structural equation modeling (SEM) analyzed relationships between KAP and demographics. The analysis included 522 (99.4%) valid questionnaires. The mean knowledge, attitude, and practice scores were 22.66 ± 4.29 (/30, 75.53%), the mean attitude score was 43.13 ± 4.54 (/60, 71.88%), and the mean practice score was 57.15 ± 10.24 (/80, 71.44%), indicating sufficient knowledge, positive attitude, and proactive practice. In the SEM, knowledge was associated with income (β = 1.01, P < 0.001), frequency of fall prevention (β=-0.55, P < 0.001), residence (β = 0.97, P = 0.030), and falls in the past year (β = 0.76, P = 0.017). Attitude was associated with knowledge (β = 0.21, P < 0.001) and alcohol (β=-1.26, P < 0.001). Practice was associated with attitude (β = 1.09, P < 0.001), frequency of fall prevention (β=-1.86, P < 0.001), and use of anti-osteoporosis drugs (β = 2.63, P < 0.001). Older adults in Ningxia demonstrated generally good KAP toward osteoporosis and hip fracture; however, targeted educational interventions addressing specific knowledge gaps may help further improve preventive practices and support behavior change.
- 8 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessKnowledge, attitude, and practice of osteoporosis and hip fracture in older Chinese adults
This study assessed the knowledge, attitude, and practices (KAP) regarding osteoporosis and hip fracture among older adults in Ningxia, China, to inform better prevention and management strategies through patient education and lifestyle changes. This cross-sectional study surveyed older adults at Ningxia Hui Autonomous Region People’s Hospital (Sep 2022–Nov 2023) using a convenience sampling method, collecting demographic data and assessing KAP scores. Structural equation modeling (SEM) analyzed relationships between KAP and demographics. The analysis included 522 (99.4%) valid questionnaires. The mean knowledge, attitude, and practice scores were 22.66 ± 4.29 (/30, 75.53%), the mean attitude score was 43.13 ± 4.54 (/60, 71.88%), and the mean practice score was 57.15 ± 10.24 (/80, 71.44%), indicating sufficient knowledge, positive attitude, and proactive practice. In the SEM, knowledge was associated with income (β = 1.01, P < 0.001), frequency of fall prevention (β=-0.55, P < 0.001), residence (β = 0.97, P = 0.030), and falls in the past year (β = 0.76, P = 0.017). Attitude was associated with knowledge (β = 0.21, P < 0.001) and alcohol (β=-1.26, P < 0.001). Practice was associated with attitude (β = 1.09, P < 0.001), frequency of fall prevention (β=-1.86, P < 0.001), and use of anti-osteoporosis drugs (β = 2.63, P < 0.001). Older adults in Ningxia demonstrated generally good KAP toward osteoporosis and hip fracture; however, targeted educational interventions addressing specific knowledge gaps may help further improve preventive practices and support behavior change.
- Open Access
- 25 December 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 56, 101008
Macrophage iron overload promotes osteoporosis via Cxcl3- and Cxcl7-mediated paracrine signaling in ovariectomized mice
- 25 December 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 56, 101008
Open AccessMacrophage iron overload promotes osteoporosis via Cxcl3- and Cxcl7-mediated paracrine signaling in ovariectomized mice
- Open Access
- 26 September 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-12
Radical surgical treatment of calcaneal osteomyelitis: clinical characteristics and treatment efficacy based on a synthesis analysis of 364 reported cases
Calcaneal osteomyelitis (CO) poses substantial therapeutic challenges due to the distinctive anatomy and function of the calcaneus. Although multiple treatment modalities are available, severe cases frequently require radical surgical interventions, such as partial or total calcanectomy, and even amputation. Nevertheless, the clinical profile of these patients is not well characterized. Consequently, this study aimed to examine and elucidate clinical characteristics and treatment outcomes of CO patients who have undergone radical surgical interventions. A systematic literature search was conducted by two independent authors across the PubMed, Embase, and Cochrane Library databases to identify English-language studies published between January 1, 2000, and December 31, 2021, focusing on patients with CO who had undergone partial or total calcanectomy, as well as limb amputation. Studies were selected based on pre-defined inclusion and exclusion criteria. Quality assessment was performed using the National Institutes of Health (NIH) assessment tool, and effective data were extracted and synthesized for analysis. Altogether 364 CO patients were enrolled, with a male-to-female ratio of 1.88:1 (188 males and 100 females). The median age at diagnosis was 58.5 years. Diabetic foot ulcers emerged as the predominant cause, and pathogen cultures indicated a high positivity rate of 97.2% (106/109). Staphylococcus aureus was the most commonly isolated strain at 33.3% (20/60), with polymicrobial infection accounting for 24.1% (19/79). The overall infection recurrence rate was 33.1% (105/317), with total calcanectomy and partial calcanectomy being 45% (18/40) and 30.4% (72/237), respectively. Among the 104 patients who underwent amputation procedures, 49 patients were subjected to primary amputations, with the remaining 55 patients receiving secondary amputations following partial or total calcanectomy. The majority of secondary amputations, specifically 78.2% (43/55), occurred after partial calcanectomy, whereas 21.8% (12/55) followed total calcanectomy. The overall mortality rate across all the 345 patients was 5.8%, with no fatalities being directly attributable to CO. In this cohort of patients that received radical surgical interventions, the majority were middle-aged males, and the diabetic foot ulcer was the leading cause. Staphylococcus aureus continued to be the most frequently isolated pathogen. Even among patients who received partial and total calcanectomy, clinical efficacy remained unsatisfactory due to high rates of infection recurrence, leading to a high incidence of secondary limb amputation.
- 26 September 2025
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 20 (1) , 1-12
Open AccessRadical surgical treatment of calcaneal osteomyelitis: clinical characteristics and treatment efficacy based on a synthesis analysis of 364 reported cases
Calcaneal osteomyelitis (CO) poses substantial therapeutic challenges due to the distinctive anatomy and function of the calcaneus. Although multiple treatment modalities are available, severe cases frequently require radical surgical interventions, such as partial or total calcanectomy, and even amputation. Nevertheless, the clinical profile of these patients is not well characterized. Consequently, this study aimed to examine and elucidate clinical characteristics and treatment outcomes of CO patients who have undergone radical surgical interventions. A systematic literature search was conducted by two independent authors across the PubMed, Embase, and Cochrane Library databases to identify English-language studies published between January 1, 2000, and December 31, 2021, focusing on patients with CO who had undergone partial or total calcanectomy, as well as limb amputation. Studies were selected based on pre-defined inclusion and exclusion criteria. Quality assessment was performed using the National Institutes of Health (NIH) assessment tool, and effective data were extracted and synthesized for analysis. Altogether 364 CO patients were enrolled, with a male-to-female ratio of 1.88:1 (188 males and 100 females). The median age at diagnosis was 58.5 years. Diabetic foot ulcers emerged as the predominant cause, and pathogen cultures indicated a high positivity rate of 97.2% (106/109). Staphylococcus aureus was the most commonly isolated strain at 33.3% (20/60), with polymicrobial infection accounting for 24.1% (19/79). The overall infection recurrence rate was 33.1% (105/317), with total calcanectomy and partial calcanectomy being 45% (18/40) and 30.4% (72/237), respectively. Among the 104 patients who underwent amputation procedures, 49 patients were subjected to primary amputations, with the remaining 55 patients receiving secondary amputations following partial or total calcanectomy. The majority of secondary amputations, specifically 78.2% (43/55), occurred after partial calcanectomy, whereas 21.8% (12/55) followed total calcanectomy. The overall mortality rate across all the 345 patients was 5.8%, with no fatalities being directly attributable to CO. In this cohort of patients that received radical surgical interventions, the majority were middle-aged males, and the diabetic foot ulcer was the leading cause. Staphylococcus aureus continued to be the most frequently isolated pathogen. Even among patients who received partial and total calcanectomy, clinical efficacy remained unsatisfactory due to high rates of infection recurrence, leading to a high incidence of secondary limb amputation.
- Open Access
- 23 September 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1657099
β-tricalcium phosphate/calcium sulfate loaded with contezolid acefosamil (MRX-4) for antimicrobial potency, prevention and killing efficacy of MRSA biofilm
Objectives: This study aimed to evaluate the antimicrobial potency and duration of contezolid acefosamil (MRX-4) combined with gentamicin against methicillin-resistant Staphylococcus aureus (MRSA) biofilms in vitro. We also compared its performance, when delivered via calcium sulfate (CS) and β-tricalcium phosphate/calcium sulfate (β-TCP/CS) carriers, with the conventional vancomycin + gentamicin regimen.Methods: Antibiotic-loaded beads containing MRX-4 + gentamicin (C + G) or vancomycin + gentamicin (V + G) were prepared using CS and β-TCP/CS carriers. Antimicrobial potency and release duration were assessed using a modified Kirby-Bauer zone of inhibition (ZOI) assay. MRSA biofilm prevention and eradication were evaluated through colony forming unit (CFU) counting and confocal laser scanning microscopy (CLSM).Results: C + G demonstrated prolonged antimicrobial activity, maintaining effective ZOIs for at least 40 days, whereas V + G lost activity by day 40 (P < 0.05). Both C + G and V + G significantly prevented biofilm formation and reduced CFUs by > 8 logs (P < 0.001), with no significant difference between carrier types. In biofilm eradication assays, both treatments reduced CFUs by 3–4 logs; however, C + G showed superior efficacy over V + G at day 3 (P < 0.01). CLSM confirmed substantial biofilm disruption and bacterial killing in C + G-treated groups.Conclusion: MRX-4 combined with gentamicin, delivered via CS and β-TCP/CS carriers, exhibits superior and sustained local antimicrobial efficacy compared to vancomycin, particularly in eradicating MRSA biofilms.
- 23 September 2025
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1657099
Open Accessβ-tricalcium phosphate/calcium sulfate loaded with contezolid acefosamil (MRX-4) for antimicrobial potency, prevention and killing efficacy of MRSA biofilm
Objectives: This study aimed to evaluate the antimicrobial potency and duration of contezolid acefosamil (MRX-4) combined with gentamicin against methicillin-resistant Staphylococcus aureus (MRSA) biofilms in vitro. We also compared its performance, when delivered via calcium sulfate (CS) and β-tricalcium phosphate/calcium sulfate (β-TCP/CS) carriers, with the conventional vancomycin + gentamicin regimen.Methods: Antibiotic-loaded beads containing MRX-4 + gentamicin (C + G) or vancomycin + gentamicin (V + G) were prepared using CS and β-TCP/CS carriers. Antimicrobial potency and release duration were assessed using a modified Kirby-Bauer zone of inhibition (ZOI) assay. MRSA biofilm prevention and eradication were evaluated through colony forming unit (CFU) counting and confocal laser scanning microscopy (CLSM).Results: C + G demonstrated prolonged antimicrobial activity, maintaining effective ZOIs for at least 40 days, whereas V + G lost activity by day 40 (P < 0.05). Both C + G and V + G significantly prevented biofilm formation and reduced CFUs by > 8 logs (P < 0.001), with no significant difference between carrier types. In biofilm eradication assays, both treatments reduced CFUs by 3–4 logs; however, C + G showed superior efficacy over V + G at day 3 (P < 0.01). CLSM confirmed substantial biofilm disruption and bacterial killing in C + G-treated groups.Conclusion: MRX-4 combined with gentamicin, delivered via CS and β-TCP/CS carriers, exhibits superior and sustained local antimicrobial efficacy compared to vancomycin, particularly in eradicating MRSA biofilms.
- Open Access
- 1 September 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (17) , e70683
Butyrate Reducing Bone Mass Loss by Regulating the Expression of m6A Methyltransferase METTL3 in Implant‐Associated Staphylococcus aureus Osteomyelitis
Staphylococcus aureus ( S. aureus ) has been identified as a hindrance to osteoblast differentiation, thereby contributing significantly to the development of osteomyelitis. Consequently, exploring pharmaceutical interventions targeting osteoblast differentiation mediated by S. aureus may present a novel approach for treating osteomyelitis. It has been reported that N6‐methyladenosine (m6A) methylation is highly associated with infection. Moreover, studies continue to validate that short‐chain fatty acids play an important role in transcriptional modification and have been considered as a potential treatment for S. aureus infection. Our research aimed to examine the impact and underlying mechanism of butyrate, a short‐chain fatty acid, in reducing the inhibitory influence exerted by S. aureus on osteoblast differentiation. The concentration of butyrate beneficial to MC3T3‐E1 cell viability was screened by Cell Counting Kit‐8 (CCK8) assay. Reverse transcription‐quantitative PCR (RT‐qPCR), Western blotting, and alkaline phosphatase (ALP)staining were used to verify the osteogenic indexes and the expression levels of m6A methylation‐related proteins in MC3T3‐E1 cells infected with S. aureus at different time points. Besides, the same methods were used to verify the effects of butyrate stimulation and METTL3 knockdown on the osteogenic ability of MC3T3‐E1 cells. H&E staining, Goldner staining, and immunohistochemical staining were used to verify the effect of butyrate on mice with endo‐plant associated S. aureus osteomyelitis. The potential mechanisms of METTL3 and autophagy in MC3T3‐E1 cells were studied by Western blotting. In vitro experiments, we found that butyrate significantly enhanced the expression of osteogenic‐related genes down‐regulated by infection in MC3T3‐E1 cells induced by S. aureus , including RUNX2, OCN, and ALP. In addition, METTL3, an important m6A methyltransferase, was significantly up‐regulated in S. aureus ‐infected MC3T3‐E1 cells, but its expression could be down‐regulated by butyrate. Inhibiting the expression of METTL3 by siRNA could effectively rescue the osteogenic markers down‐regulated by S. aureus infection in MC3T3‐E1 cells, which was similar to the results of butyrate treatment. In vivo experiments had shown that butyrate could alleviate inflammation and osteogenic activity in implant‐associated osteomyelitis. The construction of bone marrow METTL3 low‐expression mice using siRNA also showed similar effects on osteogenic activity. Additionally, Western blotting confirmed that knocking down METTL3 rescued the autophagy imbalance caused by S. aureus infection in MC3T3‐E1 cells. In general, our research demonstrated that butyrate effectively alleviated the hindrance of osteoblast activity induced by S. aureus infection by suppressing the expression of METTL3, suggesting that butyrate may be a novel treatment for S. aureus osteomyelitis.
- 1 September 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (17) , e70683
Open AccessButyrate Reducing Bone Mass Loss by Regulating the Expression of m6A Methyltransferase METTL3 in Implant‐Associated Staphylococcus aureus Osteomyelitis
Staphylococcus aureus ( S. aureus ) has been identified as a hindrance to osteoblast differentiation, thereby contributing significantly to the development of osteomyelitis. Consequently, exploring pharmaceutical interventions targeting osteoblast differentiation mediated by S. aureus may present a novel approach for treating osteomyelitis. It has been reported that N6‐methyladenosine (m6A) methylation is highly associated with infection. Moreover, studies continue to validate that short‐chain fatty acids play an important role in transcriptional modification and have been considered as a potential treatment for S. aureus infection. Our research aimed to examine the impact and underlying mechanism of butyrate, a short‐chain fatty acid, in reducing the inhibitory influence exerted by S. aureus on osteoblast differentiation. The concentration of butyrate beneficial to MC3T3‐E1 cell viability was screened by Cell Counting Kit‐8 (CCK8) assay. Reverse transcription‐quantitative PCR (RT‐qPCR), Western blotting, and alkaline phosphatase (ALP)staining were used to verify the osteogenic indexes and the expression levels of m6A methylation‐related proteins in MC3T3‐E1 cells infected with S. aureus at different time points. Besides, the same methods were used to verify the effects of butyrate stimulation and METTL3 knockdown on the osteogenic ability of MC3T3‐E1 cells. H&E staining, Goldner staining, and immunohistochemical staining were used to verify the effect of butyrate on mice with endo‐plant associated S. aureus osteomyelitis. The potential mechanisms of METTL3 and autophagy in MC3T3‐E1 cells were studied by Western blotting. In vitro experiments, we found that butyrate significantly enhanced the expression of osteogenic‐related genes down‐regulated by infection in MC3T3‐E1 cells induced by S. aureus , including RUNX2, OCN, and ALP. In addition, METTL3, an important m6A methyltransferase, was significantly up‐regulated in S. aureus ‐infected MC3T3‐E1 cells, but its expression could be down‐regulated by butyrate. Inhibiting the expression of METTL3 by siRNA could effectively rescue the osteogenic markers down‐regulated by S. aureus infection in MC3T3‐E1 cells, which was similar to the results of butyrate treatment. In vivo experiments had shown that butyrate could alleviate inflammation and osteogenic activity in implant‐associated osteomyelitis. The construction of bone marrow METTL3 low‐expression mice using siRNA also showed similar effects on osteogenic activity. Additionally, Western blotting confirmed that knocking down METTL3 rescued the autophagy imbalance caused by S. aureus infection in MC3T3‐E1 cells. In general, our research demonstrated that butyrate effectively alleviated the hindrance of osteoblast activity induced by S. aureus infection by suppressing the expression of METTL3, suggesting that butyrate may be a novel treatment for S. aureus osteomyelitis.
- Open Access
- 26 August 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 1-21
Targeting ANT1 to regulate PINK1/Parkin-mediated mitophagy is an effective treatment of trauma-induced tendon heterotopic ossification
- 26 August 2025
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 55, 1-21
Open AccessTargeting ANT1 to regulate PINK1/Parkin-mediated mitophagy is an effective treatment of trauma-induced tendon heterotopic ossification
- Open Access
- 5 July 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-21
Liposome-encapsulated AICAR hydrogel regulates macrophage metabolic reprogramming via SIK1 activation to alleviate osteoarthritis
Osteoarthritis (OA), the most prevalent joint disorder, is characterized by a complex etiology and a lack of safe and effective therapeutic interventions. Emerging evidence suggests that immune cell dysregulation plays a pivotal role in the pathogenesis of OA. Recent advancements in high-throughput sequencing technologies, along with the integration of machine learning into medical research, have provided novel insights into the molecular mechanisms underlying various diseases. However, the specific roles and mechanisms of immune-related factors in OA remain poorly understood. This study aims to identify potential biomarkers for the diagnosis and monitoring of OA progression and to explore targeted therapeutic strategies based on key genes associated with the disease. WGCNA and immune infiltration analysis identified SIK1 as a core gene involved in immune regulation during the progression of OA. In vitro experiments demonstrated that AICAR, an activator of SIK1, significantly suppressed inflammatory responses by modulating glucose and lipid metabolism in macrophages. A novel nanoliposome composite hydrogel, Gel@Lipo@AICAR, has been successfully developed for the targeted delivery of AICAR. The intra-articular administration of Gel@Lipo@AICAR demonstrated excellent biosafety and therapeutic potential in mitigating the progression of OA. This study identifies SIK1 as a novel biomarker for diagnosing and monitoring the progression of OA. The anti-inflammatory effects of its agonist, AICAR, were validated, underscoring its role in reprogramming macrophage glucose and lipid metabolism. Furthermore, the development of Gel@Lipo@AICAR, a nanoliposome composite hydrogel, presents a promising therapeutic strategy for the treatment of OA.
- 5 July 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-21
Open AccessLiposome-encapsulated AICAR hydrogel regulates macrophage metabolic reprogramming via SIK1 activation to alleviate osteoarthritis
Osteoarthritis (OA), the most prevalent joint disorder, is characterized by a complex etiology and a lack of safe and effective therapeutic interventions. Emerging evidence suggests that immune cell dysregulation plays a pivotal role in the pathogenesis of OA. Recent advancements in high-throughput sequencing technologies, along with the integration of machine learning into medical research, have provided novel insights into the molecular mechanisms underlying various diseases. However, the specific roles and mechanisms of immune-related factors in OA remain poorly understood. This study aims to identify potential biomarkers for the diagnosis and monitoring of OA progression and to explore targeted therapeutic strategies based on key genes associated with the disease. WGCNA and immune infiltration analysis identified SIK1 as a core gene involved in immune regulation during the progression of OA. In vitro experiments demonstrated that AICAR, an activator of SIK1, significantly suppressed inflammatory responses by modulating glucose and lipid metabolism in macrophages. A novel nanoliposome composite hydrogel, Gel@Lipo@AICAR, has been successfully developed for the targeted delivery of AICAR. The intra-articular administration of Gel@Lipo@AICAR demonstrated excellent biosafety and therapeutic potential in mitigating the progression of OA. This study identifies SIK1 as a novel biomarker for diagnosing and monitoring the progression of OA. The anti-inflammatory effects of its agonist, AICAR, were validated, underscoring its role in reprogramming macrophage glucose and lipid metabolism. Furthermore, the development of Gel@Lipo@AICAR, a nanoliposome composite hydrogel, presents a promising therapeutic strategy for the treatment of OA.